{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:36:17Z","timestamp":1762353377905,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["148470"],"award-info":[{"award-number":["148470"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clcc.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T20:49:38Z","timestamp":1691441378000},"page":"431-441.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends and Prescriber Variation in the Duration of Oxaliplatin-Containing Adjuvant Chemotherapy for Stage III Colon Cancer From 2007 to 2019: A Population-Based Retrospective Cohort Study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2732-3929","authenticated-orcid":false,"given":"Colin","family":"Sue-Chue-Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Brezden-Masley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinku","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Y.X.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-4620","authenticated-orcid":false,"given":"Nancy N.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2023.08.003_bib0001","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(16)32585-5","article-title":"Evidence for overuse of medical services around the world","volume":"390","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2023.08.003_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(16)32586-7","article-title":"Levers for addressing medical underuse and overuse: achieving high-value health care","volume":"390","author":"Elshaug","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2023.08.003_bib0003","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(16)30946-1","article-title":"Evidence for underuse of effective medical services around the world","volume":"390","author":"Glasziou","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2023.08.003_bib0004","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(16)30947-3","article-title":"Drivers of poor medical care","volume":"390","author":"Saini","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2023.08.003_bib0005","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.325.7370.961","article-title":"Unwarranted variations in healthcare delivery: implications for academic medical centres","volume":"325","author":"Wennberg","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.clcc.2023.08.003_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMp0809794","article-title":"Slowing the growth of health care costs \u2014 lessons from regional variation","volume":"360","author":"Fisher","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0007","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.05.013","article-title":"Does practice variation matter?","volume":"62","author":"Hlatky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0008","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0009","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0010","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1200\/JCO.2006.08.2974","article-title":"Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07","volume":"25","author":"Kuebler","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0011","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","article-title":"Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses","volume":"29","author":"Yothers","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0012","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer","volume":"29","author":"Haller","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4161","article-title":"In support of a complex IDEA-A new meta-analysis supporting the findings of the International Duration Evaluation of Adjuvant Therapy Collaboration","volume":"2","author":"Johnson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clcc.2023.08.003_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1634\/theoncologist.2019-0553","article-title":"Medical oncologists\u2019 perspectives on how the results of the IDEA collaboration impact the adjuvant treatment of stage III colon cancer","volume":"25","author":"Yu","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.clcc.2023.08.003_bib0015","first-page":"1","article-title":"Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices","volume":"28","author":"Hanna","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.clcc.2023.08.003_bib0016","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1200\/JCO.19.00281","article-title":"Duration of oxaliplatin-containing adjuvant therapy for stage III colon cancer: ASCO clinical practice guideline","volume":"37","author":"Lieu","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0017","unstructured":"National Institute for Health and Care Excellence. Colorectal cancer.; 2020. www.nice.org.uk\/guidance\/ng151. Accessed June 1, 2023."},{"key":"10.1016\/j.clcc.2023.08.003_bib0018","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.clon.2022.03.012","article-title":"Cancer trial impact: understanding implementation of the short course oncology treatment trial findings at a national level","volume":"34","author":"Hanna","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001885","article-title":"The reporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0021","first-page":"1","article-title":"Prognostic impact of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer: an ACCENT\/IDEA pooled analysis of 11 adjuvant trials","volume":"41","author":"Gallois","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.1986.4.1.115","article-title":"Analysis of survival by tumor response","volume":"4","author":"Anderson","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0023","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1200\/JOP.2014.001531","article-title":"Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer","volume":"11","author":"Wasserman","year":"2015","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clcc.2023.08.003_bib0024","unstructured":"Tan J. The processes of care after colorectal cancer surgery in ONTARIO; 2008. https:\/\/tspace.library.utoronto.ca\/handle\/1807\/17228. Accessed: June 15, 2020."},{"key":"10.1016\/j.clcc.2023.08.003_bib0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/MLR.0b013e318229360e","article-title":"The mortality risk score and the ADG score: two points-based scoring systems for the Johns Hopkins aggregated diagnosis groups to predict mortality in a general adult population Cohort in Ontario, Canada","volume":"49","author":"Austin","year":"2011","journal-title":"Med Care"},{"key":"10.1016\/j.clcc.2023.08.003_bib0026","unstructured":"Johns Hopkins University. The Johns Hopkins ACG System Version 10.0 Technical Reference Guide. 2011. https:\/\/www.hopkinsacg.org\/document\/acg-system-version-10-0-technical-reference-guide\/. Accessed June 1, 2023."},{"key":"10.1016\/j.clcc.2023.08.003_bib0027","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/gerona\/62.7.731","article-title":"Frailty: an emerging research and clinical paradigm - issues and controversies","volume":"62","author":"Bergman","year":"2007","journal-title":"J Gerontol - Ser A Biol Sci Med Sci"},{"year":"2018","series-title":"2016 Ontario Marginalization Index User Guide","author":"Matheson","key":"10.1016\/j.clcc.2023.08.003_bib0028"},{"key":"10.1016\/j.clcc.2023.08.003_bib0029","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jclinepi.2008.07.008","article-title":"Varied definitions of hospital volume did not alter the conclusions of volume-outcome analyses","volume":"62","author":"Kulkarni","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10654-018-0447-z","article-title":"A comparison of different methods to handle missing data in the context of propensity score analysis","volume":"34","author":"Choi","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0031","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"10.1016\/j.clcc.2023.08.003_bib0032","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0033","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/ije\/dyaa148","article-title":"Reflection on modern methods: a common error in the segmented regression parameterization of interrupted time-series analyses","volume":"50","author":"Xiao","year":"2021","journal-title":"Int J Epidemiol"},{"year":"2000","series-title":"An Introduction to Time Series Analysis and Forecasting: With Applications of SAS\u00ae and SPSS\u00ae","author":"Yaffee","key":"10.1016\/j.clcc.2023.08.003_bib0034"},{"year":"2018","series-title":"SAS\u00ae for Mixed Models: Introduction and Basic Applications","author":"Stroup","key":"10.1016\/j.clcc.2023.08.003_bib0035"},{"year":"2015","series-title":"Regression Modeling Strategies With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","key":"10.1016\/j.clcc.2023.08.003_bib0036"},{"key":"10.1016\/j.clcc.2023.08.003_bib0037","unstructured":"Fang J, Austin P, Tu J. Test for Linearity between Continuous Confounder and Binary Outcome First, Run a Multivariate Regression Analysis Second. 2009. https:\/\/www.researchgate.net\/profile\/Jack-Tu\/publication\/228827696_Test_for_linearity_between_continuous_confounder_and_binary_outcome_first_run_a_multivariate_regression_analysis_second\/links\/00b7d5297679d6e669000000\/Test-for-linearity-between-continuous. Accessed June 1, 2023."},{"key":"10.1016\/j.clcc.2023.08.003_bib0038","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/sim.7336","article-title":"Intermediate and advanced topics in multilevel logistic regression analysis","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0039","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MLR.0b013e31827ff0dc","article-title":"The relationship between the C-statistic of a risk-adjustment model and the accuracy of hospital report cards: a Monte Carlo study","volume":"51","author":"Austin","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.clcc.2023.08.003_bib0040","series-title":"SAS Global Forum","article-title":"Model-based risk-adjustment in clinical outocme research","author":"Fang","year":"2020"},{"key":"10.1016\/j.clcc.2023.08.003_bib0041","first-page":"65","article-title":"Managing clinical knowledge for health care improvement","author":"Balas","year":"2000","journal-title":"Yearb Med Inform"},{"key":"10.1016\/j.clcc.2023.08.003_bib0042","first-page":"CD003030","article-title":"Continuing education meetings and workshops: effects on professional practice and health care outcomes","volume":"2009","author":"Forsetlund","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clcc.2023.08.003_bib0043","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jamainternmed.2015.5441","article-title":"Early trends among seven recommendations from the choosing wisely campaign","volume":"175","author":"Rosenberg","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0044","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1200\/JOP.2016.019281","article-title":"Choosing wisely in oncology: are we ready for value-based care?","volume":"13","author":"Rocque","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clcc.2023.08.003_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13012-019-0960-9","article-title":"Unpacking the complexities of de-implementing inappropriate health interventions","volume":"15","author":"Norton","year":"2020","journal-title":"Implement Sci"},{"key":"10.1016\/j.clcc.2023.08.003_bib0047","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ijc.34149","article-title":"Translation of IDEA trial results into clinical practice: analysis of the implementation of a new guideline for colon cancer","volume":"151","author":"van Rooijen","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2023.08.003_bib0048","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ijc.33261","article-title":"Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: can a regional intervention promote national change?","volume":"148","author":"Taylor","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2023.08.003_bib0049","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.clon.2019.12.008","article-title":"Determinants of variation in the use of adjuvant chemotherapy for stage III colon cancer in England","volume":"32","author":"Boyle","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clcc.2023.08.003_bib0050","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/cncr.23958","article-title":"Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review","volume":"113","author":"Etzioni","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2023.08.003_bib0051","first-page":"1","article-title":"Colorectal cancer adjuvant chemotherapy trends among a nonelderly veteran cohort at a southern veterans health administration","volume":"5","author":"Martin","year":"2022","journal-title":"Cancer Rep"},{"key":"10.1016\/j.clcc.2023.08.003_bib0052","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.21873\/anticanres.14436","article-title":"Practice variation in the adjuvant treatment of colon cancer in the Netherlands: a population-based study","volume":"40","author":"Keikes","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clcc.2023.08.003_bib0053","first-page":"113","article-title":"Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer","volume":"12","author":"Panchal","year":"2013","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2023.08.003_bib0054","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.6004\/jnccn.2016.0166","article-title":"Delivery of adjuvant oxaliplatin for colon cancer: insights from routine clinical practice","volume":"14","author":"Satkunam","year":"2016","journal-title":"J Natl Comprehens Cancer Netw"},{"key":"10.1016\/j.clcc.2023.08.003_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.6004\/jnccn.2016.0006","article-title":"Use and effectiveness of adjuvant chemotherapy for stage III colon cancer: a population-based study","volume":"14","author":"Booth","year":"2016","journal-title":"J Natl Comprehens Cancer Netw"},{"key":"10.1016\/j.clcc.2023.08.003_bib0056","first-page":"1","article-title":"Trends in adjuvant chemotherapy use among stage III colon cancer in non-elderly and low comorbidity patients","volume":"21","author":"el Hajj","year":"2022","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2023.08.003_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jncics\/pkaa107","article-title":"Patients\u2019 preferences for 3 months vs 6 months of adjuvant chemotherapy for colon cancer","volume":"5","author":"Blinman","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.clcc.2023.08.003_bib0058","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1056\/NEJMp1510020","article-title":"Shared decision making \u2014 finding the sweet spot","volume":"374","author":"Fried","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clcc.2023.08.003_bib0059","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/cncr.27641","article-title":"Patient decision aids for cancer treatment: are there any alternatives?","volume":"119","author":"Spiegle","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2023.08.003_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4154","article-title":"Association between adjuvant chemotherapy duration and survival among patients with stage II and III colon cancer: a systematic review and meta-analysis","volume":"2","author":"Boyne","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:09:22Z","timestamp":1761520162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002823000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1533002823000762"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2023.08.003","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and Prescriber Variation in the Duration of Oxaliplatin-Containing Adjuvant Chemotherapy for Stage III Colon Cancer From 2007 to 2019: A Population-Based Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}